HEMOSTATIC ALTERATIONS DURING BRUTON KINASE INHIBITORS TREATMENT
Patients with chronic lymphocytic leukemia (CLL) are at increased risk for major bleeding compared with the general population. The hazard ratio (HR) for major bleeding among 6,717 treated CLL/SLL patients compared with 14816 matched noncancer patients was 8.3 (95% confidence interval [CI]: 7.5-9.2...
| Published in: | Haematologica |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2025-10-01
|
| Online Access: | https://haematologica.org/article/view/12916 |
